R6D

6-(6-aminopyrazin-2-yl)-N-{4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}imidazo[1,2-a]pyrazin-8-amine


Toggle HydrogenToggle Labels

Chemical Component Summary

Name6-(6-aminopyrazin-2-yl)-N-{4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl}imidazo[1,2-a]pyrazin-8-amine
SynonymsGS-9876
Identifiers6-(6-azanylpyrazin-2-yl)-~{N}-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine
FormulaC23 H25 N9 O
Molecular Weight443.504
TypeNON-POLYMER
Isomeric SMILESc1cc(ccc1Nc2c3nccn3cc(n2)c4cncc(n4)N)N5CCN(CC5)C6COC6
InChIInChI=1S/C23H25N9O/c24-21-12-25-11-19(28-21)20-13-32-6-5-26-23(32)22(29-20)27-16-1-3-17(4-2-16)30-7-9-31(10-8-30)18-14-33-15-18/h1-6,11-13,18H,7-10,14-15H2,(H2,24,28)(H,27,29)
InChIKeyXCIGZBVOUQVIPI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count58
Chiral Atom Count0
Bond Count63
Aromatic Bond Count22

Drug Info: DrugBank

DrugBank IDDB14770 
NameLanraplenib
Groups investigational
DescriptionLanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).
SynonymsLanraplenib
CAS number1800046-95-0

Related Resource References

Resource NameReference
Pharos CHEMBL3986824
PubChem 118161062
ChEMBL CHEMBL3986824